Literature DB >> 12175777

Fabry disease: 45 novel mutations in the alpha-galactosidase A gene causing the classical phenotype.

Junaid Shabbeer1, Makiko Yasuda, Edlira Luca, Robert J Desnick.   

Abstract

The nature of the molecular lesions in the alpha-galactosidase A (alpha-Gal A) gene causing Fabry disease was determined in 50 unrelated families with the classic phenotype of this X-linked recessive lysosomal storage disease. Genomic DNA was isolated from affected males or obligate carrier females, and the entire alpha-Gal A coding region as well as the flanking and intronic sequences were analyzed by PCR amplification and automated sequencing. Forty-five new mutations were identified including 38 single base substitutions (32 missense and four nonsense) and nine gene rearrangements: MIR, M42T, G43D, G43V, H46Y, F50C, L68F, G132R, T141I, Y152X, K168R, G183S, V199M, P205R, Y207S, Q221X, C223R, C223Y, D234Y, G271C, A288P, P293A, R301G, I303N, I317T, E341D, P362L, R363C, R363H, G373D, I384N, T385P, Q396X, E398K, S401X, P409A, g7325insC, g7384del13, g8341delG, g8391del4/ins3, g10511delTAGT, g10704delACAG, g11019insG, g11021insG, and g11048delAGG. In the remaining five Fabry families, four previously reported mutations were detected (W81X, R112C, g11011delTC, and g11050delGAG) of which the R112C substitution was found in two families who were unrelated by haplotyping. These studies further define the heterogeneity of mutations in the alpha-Gal A gene causing the classical Fabry disease phenotype, and permit precise carrier detection and prenatal diagnosis in these families.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12175777     DOI: 10.1016/s1096-7192(02)00012-4

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  34 in total

1.  Target-enrichment sequencing and copy number evaluation in inherited polyneuropathy.

Authors:  Wei Wang; Chen Wang; D Brian Dawson; Erik C Thorland; Patrick A Lundquist; Bruce W Eckloff; Yanhong Wu; Saurabh Baheti; Jared M Evans; Steven S Scherer; Peter J Dyck; Christopher J Klein
Journal:  Neurology       Date:  2016-04-13       Impact factor: 9.910

2.  Mutational analysis of the GLA gene in Mexican families with Fabry disease.

Authors:  Bianca Ethel Gutiérrez-Amavizca; Andreas Gal; Rocío Ortíz-Orozco; Ulrich Orth; Ernesto Prado Montes De Oca; Jaime Paul Gutiérrez-Amavizca; Luis E Figuera
Journal:  J Genet       Date:  2017-03       Impact factor: 1.166

3.  The alpha-galactosidase A p.Arg118Cys variant does not cause a Fabry disease phenotype: data from individual patients and family studies.

Authors:  Susana Ferreira; Alberto Ortiz; Dominique P Germain; Miguel Viana-Baptista; António Caldeira-Gomes; Marta Camprecios; Maria Fenollar-Cortés; Ángel Gallegos-Villalobos; Diego Garcia; José Antonio García-Robles; Jesús Egido; Eduardo Gutiérrez-Rivas; José Antonio Herrero; Sebastián Mas; Raluca Oancea; Paloma Péres; Luis Manuel Salazar-Martín; Jesús Solera-Garcia; Helena Alves; Scott C Garman; João Paulo Oliveira
Journal:  Mol Genet Metab       Date:  2014-11-09       Impact factor: 4.797

4.  High-risk screening for Anderson-Fabry disease in patients with cardiac, renal, or neurological manifestations.

Authors:  Naoki Nakagawa; Jun Sawada; Naka Sakamoto; Toshiharu Takeuchi; Fumihiko Takahashi; Jun-Ich Maruyama; Ken Momosaki; Kimitoshi Nakamura; Fumio Endo; Naoyuki Hasebe
Journal:  J Hum Genet       Date:  2019-06-19       Impact factor: 3.172

5.  Frequency of unrecognized Fabry disease among young European-American and African-American men with first ischemic stroke.

Authors:  Marcella A Wozniak; Steven J Kittner; Stanley Tuhrim; John W Cole; Barney Stern; Mark Dobbins; Marie E Grace; Irina Nazarenko; Robert Dobrovolny; Eric McDade; Robert J Desnick
Journal:  Stroke       Date:  2009-12-10       Impact factor: 7.914

6.  The pharmacological chaperone 1-deoxygalactonojirimycin increases alpha-galactosidase A levels in Fabry patient cell lines.

Authors:  E R Benjamin; J J Flanagan; A Schilling; H H Chang; L Agarwal; E Katz; X Wu; C Pine; B Wustman; R J Desnick; D J Lockhart; K J Valenzano
Journal:  J Inherit Metab Dis       Date:  2009-04-18       Impact factor: 4.982

7.  Structure-function relationships in alpha-galactosidase A.

Authors:  Scott C Garman
Journal:  Acta Paediatr       Date:  2007-04       Impact factor: 2.299

8.  Structural characterization of mutant alpha-galactosidases causing Fabry disease.

Authors:  Kanako Sugawara; Kazuki Ohno; Seiji Saito; Hitoshi Sakuraba
Journal:  J Hum Genet       Date:  2008-07-17       Impact factor: 3.172

9.  Fabry disease: novel alpha-galactosidase A 3'-terminal mutations result in multiple transcripts due to aberrant 3'-end formation.

Authors:  Makiko Yasuda; Junaid Shabbeer; Makiko Osawa; Robert J Desnick
Journal:  Am J Hum Genet       Date:  2003-06-06       Impact factor: 11.025

10.  Fabry disease: identification of 50 novel alpha-galactosidase A mutations causing the classic phenotype and three-dimensional structural analysis of 29 missense mutations.

Authors:  Junaid Shabbeer; Makiko Yasuda; Stacy D Benson; Robert J Desnick
Journal:  Hum Genomics       Date:  2006-03       Impact factor: 4.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.